Quantcast
Last updated on April 18, 2014 at 21:21 EDT

Latest Heart failure Stories

2013-09-23 16:24:11

Session will highlight the results of recent heart failure trials ORLANDO, Fla., Sept. 23, 2013 /PRNewswire/ -- The Heart Failure Society of America (HFSA) 17(th) Annual Scientific Meeting will include a Late Breaking Clinical Trials Symposium today. The session will describe the results of recent trials and discuss their implications for the care of patients with heart failure. The Late Breaking Clinical Trials session will feature a variety of presentations on the results of recent trials...

2013-09-23 12:26:32

Effective Strategies in Caring for Patients ORLANDO, Fla., Sept. 23, 2013 /PRNewswire/ -- The Heart Failure Society of America (HFSA) 17(th) Annual Scientific Meeting will feature a How-To Session entitled "Managing End-of-Life Care in Heart Failure," a one hour interactive conference focused on this specific group of heart failure patients. The session will be led by Ann Laramee, APRN-BC, and Erin Donaho, APN. This session will offer practical skills to assist practitioners in...

2013-09-23 08:29:20

How heart failure practitioners will be impacted by the Affordable Care Act ORLANDO, Fla., Sept. 23, 2013 /PRNewswire/ -- The Heart Failure Society of America (HFSA) 17(th) Annual Scientific Meeting will open with a plenary session entitled "The Impact of Healthcare Reform." The session will feature presentations from Dr. Michael Chernew, M.D., Dr. Vivian Ho, Ph.D., and Ms. Ellen Zane. The session will focus on identifying key features of the Affordable Care Act (ACA) and...

2013-09-22 12:20:22

Joint Session with American Heart Association to Focus on Strategies to Prevent the Disease ORLANDO, Fla., Sept. 22, 2013 /PRNewswire/ -- The 17(th) Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session today entitled "The Prevention of Heart Failure." The session is being presented by HFSA and the American Heart Association. Dr. Jay Cohn, Professor of Medicine at the University of Minnesota Medical School, will discuss the abnormalities of...

2013-09-22 08:20:26

September 22-25 2013, Peabody Orlando, Orlando, FL. ORLANDO, Sept. 22, 2013 /PRNewswire/ -- The Heart Failure Society of America's (HFSA) 17(th) Annual Scientific Meeting convenes Sunday, September 22, 2013 at the Peabody Orlando Hotel. This four-day meeting--a forum for heart failure specialists to present research findings and advances in treatment--will address emerging trends in research and new developments in the approach to treating patients with all stages of heart failure. The 2013...

2013-09-20 23:22:05

The Feinstein Institute for Medical Research has been approved to receive a $1.35 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study if telehealth programs are effective self-management tools for patients with chronic disease. Renee Pekmezaris, PhD, will lead the research project, which will evaluate the success of telehealth in managing the health of elderly African Americans who have suffered heart failure. Manhasset, NY (PRWEB) September 20,...

2013-09-20 16:24:05

OAKLAND, Calif., Sept. 20, 2013 /PRNewswire/ -- Digoxin, a drug commonly used to treat heart conditions, was associated with a 72 percent higher rate of death among adults with newly diagnosed systolic heart failure, according to a Kaiser Permanente study that appears in the current online issue of Circulation: Cardiovascular Quality and Outcomes. (Logo: http://photos.prnewswire.com/prnh/20130718/SF49717LOGO) Digoxin is a drug derived from digitalis, a plant that has been used for...

2013-09-16 12:28:12

LAVAL, QC, Sept. 16, 2013 /CNW/ - Actelion Pharmaceuticals Canada Inc. announced today that CARIPUL®( )(epoprostenol) for Injection is now available in Canada. CARIPUL® is a prescription medication indicated for the long-term intravenous treatment of primary pulmonary hypertension (or idiopathic pulmonary arterial hypertension), and secondary pulmonary hypertension due to scleroderma spectrum of diseases in NYHA functional Class III and Class IV patients who did not respond...

2013-09-16 08:30:24

COLUMBUS, Ohio, Sept. 16, 2013 /PRNewswire/ -- The Healthcare Accreditation Colloquium announced today that Children's Hospital of Philadelphia (CHOP) became the first Accredited Pediatric Heart Failure Institute in Pennsylvania and third in the nation following nearly a year of work culminating in an in-depth onsite review. (Photo: http://photos.prnewswire.com/prnh/20130916/PH80202) "Children's Hospital of Philadelphia continues in its long tradition by bringing a world-class team of heart...

2013-09-11 08:28:10

CHAPEL HILL, N.C., Sept. 11, 2013 /PRNewswire/ -- Cardioxyl Pharmaceuticals, Inc. announced today the appointment of Shi Yin Foo, M.D., Ph.D., as Chief Medical Officer (CMO). Dr. Foo, who has broad experience in the development of cardiovascular drugs and translational medicine, is well positioned to help Cardioxyl realize the potential of its nitroxyl (HNO) technology for the treatment of patients with serious cardiovascular disease. Dr. Foo joins Cardioxyl from Novartis, where she...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »